NewLeaf Brands Inc. (OTC: NLBIF) (CSE: NLB) is pleased to announce that it has appointed Damon Michaels to the position of Chief Operations Officer (COO). Mr. Michaels previously served on the management team of Ebbu, a leading multi-platform cannabinoid research and technology firm based in Colorado. Prior to Ebbu’s $429MM acquisition by Canopy Growth, Mr. Michaels managed Ebbu’s day-to-day operations, including oversight of production, R&D, HR, compliance, supply chain, marketing and business development.
Mr. Michaels also provided guidance for strategic business practices and strategy driving forward the company’s mission to develop consistent products that elevate cannabis into the worldwide mainstream market.
After Canopy’s acquisition of Ebbu, Mr. Michaels has focused his attention on the thriving medical mushroom space, co-founding Mydecine Group (“Mydecine”). Mydecine is a vertically integrated company engaged to apply the vast medicinal, health and wellness capabilities of the multitude of compounds found in mycology as a whole.
“I’ve known and worked with Damon for several years in various capacities in the cannabis industry and always knew how incredibly sharp he is. Whatever Damon steps into, he goes in 110%. Through this, Damon has seen wild success through his time at EBBU resulting in a acquisition valued at $429MM by Canopy. When I caught wind that Damon was working on something in the Mycology space, I knew I had to be involved. Damons rolodex of incredibly talented and smart people is vastly extensive and has already proven to be invaluable to the company. We are so excited to have Damon join the team and are looking forward to an amazing road ahead,” said Joshua Bartch, CEO, NewLeaf Brands Inc.
“He will transition to overseeing the day to day operations for NewLeaf Brands’ as well as working to position its mycology segment for optimal future growth,” added Bartch.
“I have strong belief and passion that the world of fungi has vast opportunity for not only medicinal psychedelic research and non-psychedelic retail products, but feel we can also gain enormous momentum to tackle the multiple angles of sustainability applications utilizing the amazing effects of mycelium. Mydecine is poised to be a global fungi leader, especially with our amazing team dynamic and the help from collaborative efforts of others who share the same passion.” – Damon Michael – COO – NewLeaf Brands, Inc.
About NewLeaf Brands
NewLeaf Brands Inc. is the parent company operating innovative product divisions in the Naturally Sourced Therapies (NST) space. While controlling a variety of Psilocybin and hemp-derived CBD brands that design, manufacture and distribute cutting edge products, NewLeaf Brands Inc. further enhances its portfolio with numerous cultivation properties, retail locations, and other land assets.
NewLeaf Brands Inc. is the progressive and innovative Naturally Sourced Therapies (NST) lifestyle group known around the globe. Focusing on the rapidly emerging psilocybin and psychedelic medicines market, the Company’s wholly-owned subsidiary 1220611 B.C. Ltd. (operating as Mydecine Group) (“Mydecine”) is a vertically integrated company engaged to utilize the vast medicinal, health and wellness capabilities of the various compounds found in mycology as a whole. Established to parallel the early emergence of the industry, Mydecine aims to be a pioneer in the cultivation, processing, product development, and research and development of mycology’s exciting compounds through its three divisions, “Mydecine Farms,” “Mydecine Wellness” and “Mydecine Labs.” Furthermore, the Company’s wholly-owned subsidiaries in the hemp-derived CBD space, We are Kured LLC, Drink Fresh Water LLC, Relyfe Brand LLC, Fresh Water CBD LLC and TeaLief Brand LLC have quickly developed into market leaders and maintain extensive retail and cultivation land investments in the United States.